✦ LIBER ✦

Treatment of ongoing experimental myasthenia gravis with short term high dose cyclophosphamide

✍ Scribed by Dr. Alan Pestronk; Daniel B. Drachman; Robert N. Adams

Publisher: John Wiley and Sons
Year: 1982
Tongue: English
Weight: 505 KB
Volume: 5
Category: Article
ISSN: 0148-639X
DOI: 10.1002/mus.880050115

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of refractory myasthenia: “Reb

Treatment of refractory myasthenia: “Rebooting” with high-dose cyclophosphamide

✍ Daniel B. Drachman; Richard J. Jones; Robert A. Brodsky 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

Long-term follow-up of a phase I study o

Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias

✍ Marcos de Lima; Farhad Ravandi; Munir Shahjahan; Borje Andersson; Daniel Couriel 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## Abstract ## BACKGROUND Decitabine is a hypomethylating agent that has activity in patients with leukemia. The authors combined decitabine with busulfan and cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic stem cell transplantation. ## METHODS Patients with high‐ris